Seki Takaomi, Suzuki Hideki, Takayama Yoshiyasu, Morishita Yohei, Taniguchi Kosuke, Kawabata-Iwakawa Reika, Yokobori Takehiko, Ikota Hayato, Shirakura Takahiro, Araki Kenichiro, Hata Kenichiro, Shirabe Ken
Department of Surgery, Isesaki Municipal Hospital, Isesaki, Gunma, Japan.
Department of General Surgical Science, Division of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Gunma University, Maebashi, Gunma, Japan.
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.24-0097. Epub 2025 Jun 7.
Among neuroendocrine neoplasms (NENs), non-neuroendocrine and NEN components may rarely coexist, which are referred to as mixed neuroendocrine-non-NENs (MiNENs). Most gallbladder MiNENs are progressive and associated with neuroendocrine carcinoma (NEC), but rarely with neuroendocrine tumor (NET) as a component. To our knowledge, there are 4 reported cases of mixed gallbladder tumors with NET as a component. From the genetic analysis of MiNENs consisting of NEC, MiNEN is believed to have a common origin, as each tumor component shares a common mutation. Our case is an extremely rare reported case of a mixed gallbladder tumor with a NET component as a MiNEN, and the first reported case of whole-exome analysis performed on a resected specimen.
A 77-year-old woman presented to our hospital with epigastric pain. An emergency laparoscopic cholecystectomy was performed with a diagnosis of acute gallstone cholecystitis. Pathological examination revealed gallbladder MiNEN (adenocarcinoma + NET G2). Additional surgery was performed, but no residual tumor was found. The patient has been recurrence-free for 36 months after surgery without adjuvant therapy. The origin of the tumor was examined. Macroscopically, adenocarcinoma cells were present on both sides of the NET, while microscopically, some adenocarcinoma cells were positive for neuroendocrine markers (synaptophysin and chromogranin A). Staining for p53 showed wild-type staining with scattered, weakly expressing cells in both tumors. Subsequently, we performed whole-exome sequencing of each tumor component. The results showed that each tumor component shared c.1015G>T (p.Glu339Ter), c.889G>A (p.Asp297Asn), and c.416G>A (p.Gly139Asp) mutations, suggesting that the adenocarcinoma might have differentiated into NET G2.
In this case report, the tumors shared a common genetic mutation, suggesting that MiNENs with NET components may share a common origin. Furthermore, the NEN component of MiNEN occurring in the gallbladder was associated with a mutation, despite the low frequency of mutations in normal NETs.
在神经内分泌肿瘤(NENs)中,非神经内分泌和NEN成分可能很少共存,这被称为混合性神经内分泌-非神经内分泌肿瘤(MiNENs)。大多数胆囊MiNENs呈进行性发展,并与神经内分泌癌(NEC)相关,但很少与神经内分泌肿瘤(NET)作为一个成分相关。据我们所知,有4例报告的以NET为成分的混合性胆囊肿瘤病例。从由NEC组成的MiNENs的基因分析来看,MiNEN被认为有共同的起源,因为每个肿瘤成分都有一个共同的突变。我们的病例是一例极其罕见的报告病例,为以NET为成分的混合性胆囊肿瘤,作为MiNEN,也是首例对切除标本进行全外显子组分析的报告病例。
一位77岁女性因上腹部疼痛就诊于我院。诊断为急性结石性胆囊炎后进行了急诊腹腔镜胆囊切除术。病理检查显示为胆囊MiNEN(腺癌+NET G2)。进行了额外的手术,但未发现残留肿瘤。患者术后36个月无复发,未接受辅助治疗。对肿瘤的起源进行了检查。宏观上,NET两侧均有腺癌细胞,而微观上,一些腺癌细胞的神经内分泌标志物(突触素和嗜铬粒蛋白A)呈阳性。p53染色显示野生型染色,两个肿瘤中均有散在的、弱表达的细胞。随后,我们对每个肿瘤成分进行了全外显子组测序。结果显示,每个肿瘤成分都有c.1015G>T(p.Glu339Ter)、c.889G>A(p.Asp297Asn)和c.416G>A(p.Gly139Asp)突变,提示腺癌可能已分化为NET G2。
在本病例报告中,肿瘤有共同的基因突变,提示具有NET成分的MiNENs可能有共同的起源。此外,发生在胆囊的MiNEN的NEN成分与一个突变相关,尽管正常NETs中突变频率较低。